Nianping Chen

567 total citations
18 papers, 457 citations indexed

About

Nianping Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Nianping Chen has authored 18 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Nianping Chen's work include Cancer-related Molecular Pathways (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Nianping Chen is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Nianping Chen collaborates with scholars based in China, Iran and Hong Kong. Nianping Chen's co-authors include Mingyi Li, Runzhi Zhu, Jie Liu, Qingyu Zhang, Huilai Miao, Juan Xia, Juntao Liu, Qingyu Zhang, Bin Liu and Wei Zhou and has published in prestigious journals such as Scientific Reports, BioMed Research International and Journal of Cellular Biochemistry.

In The Last Decade

Nianping Chen

18 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nianping Chen China 12 284 96 79 65 60 18 457
Mayrel Palestino Domínguez Mexico 9 201 0.7× 81 0.8× 99 1.3× 15 0.2× 21 0.3× 13 439
Saeeda O. Ahmed Saudi Arabia 13 312 1.1× 113 1.2× 140 1.8× 80 1.2× 30 0.5× 28 620
Bhupender Kumar India 15 315 1.1× 173 1.8× 57 0.7× 22 0.3× 15 0.3× 28 490
Addanki P. Kumar United States 9 265 0.9× 87 0.9× 69 0.9× 14 0.2× 35 0.6× 10 432
Yuting Wu China 14 351 1.2× 131 1.4× 104 1.3× 43 0.7× 6 0.1× 30 567
Xiaodan Sun China 14 304 1.1× 121 1.3× 113 1.4× 11 0.2× 66 1.1× 39 556
I‐Lu Lai Taiwan 16 567 2.0× 270 2.8× 137 1.7× 22 0.3× 15 0.3× 20 775
Darko Castven Germany 10 229 0.8× 114 1.2× 106 1.3× 17 0.3× 6 0.1× 22 425
Jianyang Hu China 11 354 1.2× 100 1.0× 92 1.2× 29 0.4× 9 0.1× 16 511

Countries citing papers authored by Nianping Chen

Since Specialization
Citations

This map shows the geographic impact of Nianping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nianping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nianping Chen more than expected).

Fields of papers citing papers by Nianping Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nianping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nianping Chen. The network helps show where Nianping Chen may publish in the future.

Co-authorship network of co-authors of Nianping Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Nianping Chen. A scholar is included among the top collaborators of Nianping Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nianping Chen. Nianping Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Fang, Shuo, et al.. (2023). Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis. Open Life Sciences. 18(1). 20220652–20220652. 6 indexed citations
4.
Xu, Hao, et al.. (2021). The landscape of PD-L1 expression and somatic mutations in hepatocellular carcinoma. Journal of Gastrointestinal Oncology. 12(3). 1132–1140. 11 indexed citations
5.
Farzaneh, Maryam, et al.. (2021). MicroRNAs: Crucial Players in the Differentiation of Human Pluripotentand Multipotent Stem Cells into Functional Hepatocyte-Like Cells. Current Stem Cell Research & Therapy. 17(8). 734–740. 2 indexed citations
6.
Chen, Ming, et al.. (2020). Giant recurrent left inguinal hernia with femoral nerve injury: a report of a rare case. BMC Surgery. 20(1). 123–123. 3 indexed citations
7.
Xu, Hao, Ming Chen, Xiaoyu Tan, et al.. (2020). Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma. Cancer Medicine. 9(6). 2062–2076. 12 indexed citations
8.
Dai, Wei, Shuo Fang, Qiurong Ye, et al.. (2020). CDKN3 expression predicates poor prognosis and regulates adriamycin sensitivity in hepatocellular carcinoma in vitro. Journal of International Medical Research. 48(7). 1220736431–1220736431. 9 indexed citations
9.
Dai, Wei, Huilai Miao, Shuo Fang, et al.. (2016). CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma. Molecular Medicine Reports. 14(2). 1509–1514. 26 indexed citations
10.
Liu, Bin, Yufeng Shi, Qingyu Zhang, et al.. (2016). Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells. Molecular Medicine Reports. 14(1). 159–164. 23 indexed citations
11.
Zhang, Qingyu, Tao Fang, Wenhua Hu, et al.. (2015). Notch3 functions as a regulator of cell self-renewal by interacting with the β-catenin pathway in hepatocellular carcinoma. Oncotarget. 6(6). 3669–3679. 44 indexed citations
12.
Zhang, Qingyu, Jie Liu, Bin Liu, et al.. (2014). Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism. Scientific Reports. 4(1). 4628–4628. 67 indexed citations
13.
Liu, Bin, Wei Zhou, Jie Liu, et al.. (2014). Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G1/S-phase cell cycle arrest and apoptosis through caspase/cyclin-CDK pathways. Molecular Medicine Reports. 10(4). 1697–1702. 72 indexed citations
14.
Liu, Bin, Wei Zhou, Xiaofeng Chen, et al.. (2014). Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway. Molecular Medicine Reports. 11(3). 1609–1614. 27 indexed citations
15.
Wu, Zhiyuan, Bin Liu, Jie Liu, et al.. (2014). Resveratrol inhibits the proliferation of human melanoma cells by inducing G1/S cell cycle arrest and apoptosis. Molecular Medicine Reports. 11(1). 400–404. 50 indexed citations
16.
Xu, Xiaohong, Liangping Luo, Jiexin Chen, et al.. (2014). Acoustic Radiation Force Impulse Elastography for Efficacy Evaluation after Hepatocellular Carcinoma Radiofrequency Ablation: A Comparative Study with Contrast-Enhanced Ultrasound. BioMed Research International. 2014. 1–7. 13 indexed citations
17.
Hu, Min, Haili Huang, Rui Zhao, et al.. (2013). AZD8055 induces cell death associated with autophagy and activation of AMPK in hepatocellular carcinoma. Oncology Reports. 31(2). 649–656. 42 indexed citations
18.
Miao, Huilai, Changjiang Lei, Jinhua Wen, et al.. (2012). Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down‐regulation of YAP. Journal of Cellular Biochemistry. 114(3). 625–631. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026